» Articles » PMID: 24492857

Effects of Erythropoietin on Ischemia, Follicular Survival, and Ovarian Function in Ovarian Grafts

Overview
Journal Reproduction
Date 2014 Feb 5
PMID 24492857
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Ovarian tissue transplantation is performed to preserve fertility in patients undergoing chemotherapy and radiotherapy. However, ischemia/reperfusion (IR) injury and free radical production occurring during the revascularization of the transplanted tissue are the major limitations of this procedure. The aim of this study was to investigate the effect of erythropoietin (EPO) as an antioxidant on oxidative stress and ovary survival following transplantation. The Naval Medical Research Institute (NMRI) mice (4-5 weeks old) were divided into three groups (six mice per group): control; autograft+saline, and autograft+EPO (500  IU/kg i.p.). After 28 days, ovary compartments were estimated stereologically. DNA fragmentation and plasma malondialdehyde (MDA), progesterone, and estradiol (E2) concentrations were also evaluated. The results were analyzed using one-way ANOVA and Tukey's test, and the means were significantly different at P<0.05. The mean total volume of ovary, cortex, and medulla and the number of follicles increased significantly in the autograft+EPO group (P<0.01). Apoptosis rate in the autograft+EPO group was lower than that in the autograft+saline group. The concentration of MDA decreased significantly in the autografted EPO-treated group than in the autografted saline-treated group (P<0.01). The concentration of E2 increased significantly in the autograft+EPO group than in the autograft+saline group (P<0.01). EPO reduced IR injury, increasing follicle survival and function in grafted ovaries. Free Persian abstract A Persian (Farsi) translation of the abstract is freely available online at http://www.reproduction-online.org/content/147/5/733/suppl/DC1.

Citing Articles

Research progress on mechanism of follicle injury after ovarian tissue transplantation and protective strategies.

Ying H, Shi L, Zhang S Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024; 53(3):321-330.

PMID: 38562041 PMC: 11348700. DOI: 10.3724/zdxbyxb-2023-0566.


Comparison of orthotopic and heterotopic autologous ovarian tissue transplantation outcomes.

Oktay K, Marin L Fertil Steril. 2023; 121(1):72-79.

PMID: 37839723 PMC: 11073798. DOI: 10.1016/j.fertnstert.2023.10.015.


Roles of follicle stimulating hormone and sphingosine 1-phosphate co-administered in the process in mouse ovarian vitrification and transplantation.

Wang F, Tian Y, Huang L, Qin T, Ma W, Pei C J Ovarian Res. 2023; 16(1):173.

PMID: 37620938 PMC: 10463983. DOI: 10.1186/s13048-023-01206-1.


Ovarian tissue cryopreservation and transplantation: a review on reactive oxygen species generation and antioxidant therapy.

Najafi A, Asadi E, Benson J Cell Tissue Res. 2023; 393(3):401-423.

PMID: 37328708 DOI: 10.1007/s00441-023-03794-2.


Fertility preservation in pediatric healthcare: a review.

Chen L, Dong Z, Chen X Front Endocrinol (Lausanne). 2023; 14:1147898.

PMID: 37206440 PMC: 10189781. DOI: 10.3389/fendo.2023.1147898.